Novartis, SciNeuro to Work Together on Preclinical Amyloid-Targeting Drug for Alzheimer’s
Keep an Eye on These 15 Biotech Companies in 2026
Novartis Breaks Ground on San Diego Biomedical R&D Site
Biotech in 2025: A Retrospective
Novartis Licenses Radiopharma Asset From Chinese Biotech for $50M Upfront
AstraZeneca Leads Big Pharma’s AI Clinical Trials Revolution with Real-World Patient Impact
Fragment Merging – and Flipping – on the Leucine Zipper of MITF
JPM26: Filling C-Suites, Union Square—And Elevators—With Pink
Proteasomes: A Novel Approach to Target the Immune System
A Protein Found in the GI Tract Can Neutralize Many Bacteria
CMS's Medicare Price Negotiations Start Round Three
Enliven’s Phase 1 Leukemia Pill Data Look Competitive with Novartis and Terns
Novartis Says Generics to Erode $4B From 2026 Sales
With De-Risking the Mantra, Novartis Expands Presence in RNAi: Narasimhan in Conversation
Proliferating Patents, Lawsuits Stave Off Pharmas’ Generic Competitors
Novartis to Divest India Unit to Private Equity-Led Consortium for $159M
Facing Talent Crunch, Radiopharma Field Casts a Wide Net
Industry Outlook 2026: The Impact of Novel Therapies
J&J Bets on Isomorphic for AI-Powered Drug Hunt
Novartis Doesn’t Have a GLP-1. They Don’t Miss It In a World Of Me-Toos
Ionis Paves Its Own Path as Initial Tryngolza Launch Defies Expectations
Ex-Novartis CMO John Tsai Joins Daiichi Sankyo
2026 Cardiovascular Catalysts: Lp(a) on the Horizon
Vyriad Raises Final $25M Series B Tranche
Bayer and Cradle Enter Collaboration to Enhance AI-Enabled Antibody Discovery and Optimization
Novartis to Build Fourth US Radiotherapy Factory in Florida
Novartis Cuts 6 Early Cancer Candidates, Adds 2 to Refine Oncology Strategy
GSK Reaches $2.2bn Deal to Buy Food Allergy Biotech RAPT
Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience
Novartis' Oral BTK Drug Moves the Needle in CINDU
Biopharmas Axed 47% More Employees Year Over Year
Pharma Bets Big on AI Platforms with Flurry of New Year Deals
The New WIZ-Kid in Protein Degradation
Arrowhead Enters Obesity Chat by Doubling Tirzepatide’s Weight Loss in Combo Study
BioSpace’s NextGen Class of 2026 Attracts Big Bucks From Tight Wallets
Novartis Issues a Life Sciences Warning in a 'G-Zero' World
IRA Drug Pricing Petitions Pile up at the Supreme Court
JPM 2026: What’s the Outlook Like This Year?
Hepatotoxicity Headaches: One of the Hardest Risks to De-Risk
Eight of the Biggest Immunology and Inflammation (I&I) Deals in 2025
A Clearer Path to Relief: Sinusitis Treatments on the Way
Vyriad Raises $25M Series B Round
Patent Losses Hit Novartis Hard, but CEO Has a Plan
Data Builds on Roche's Dominance in Primary Progressive MS
What Sanofi’s Multiple Sclerosis Troubles Could Mean for the Space